CIK 0001501989 · Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273521219
- Phone
- 650.515.3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- 8-K Event Executive or director change
- 8-K Event Results of operations
- 10-K Report Annual Report
- 8-K Event Regulation FD disclosure
- 8-K Event Executive or director change
- 8-K Event Executive or director change
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations
- 8-K Event Other events
- 8-K Event Results of operations
- 8-K Event Shareholder vote results
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations
- DEF 14A Proxy Proxy Statement
- 10-K/A Report 10-K/A
- 8-K Event Results of operations
- 10-K Report Annual Report
Page 6 of 8 · 158 filings